MGMT repletion after treatment of glioblastoma cells with temozolomide and O6-benzylguanine implicates NFκB and mutant p53

Author: Vlachostergios Panagiotis J   Hatzidaki Eleana   Papandreou Christos N  

Publisher: Maney Publishing

ISSN: 1743-1328

Source: Neurological Research, Vol.35, Iss.8, 2013-10, pp. : 879-882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content